Latest Flu Stats, Prevention, and New Drug from GenenTech

Dr. Michael Ison from the Feinberg School of Medicine at Northwestern University discusses the current flu season as well as the latest information in flu prevention and treatment options, including the new drug Xofluza (Baloxavir Marboxil) by Genentech.

Dr. Michael Ison’s primary clinical and research area focuses on infections in transplant recipients. His research is further focused on viral infections including norovirus, CMV and respiratory viral infections (influenza, adenovirus) in transplant recipients.

Liked it? Take a second to support healthprofessionalradio on Patreon!

0 Comments

Leave a Reply

You must be logged in to post a comment.